Company
Mirae Asset Venture Investment
Investments
| Company | Round | Date | Lead |
|---|---|---|---|
| LinqAlpha | Series A | 2026-07-02 | |
| Crossbow Therapeutics | Series B | 2026-03-19 | |
| Upstage | Series B Funding | 2024-04-16 | |
| Accent Therapeutics | Series C | 2024-01-23 | |
| Agtonomy | Seed III | 2022-09-19 | Lead |
| Fountain | Series C extension | 2022-06-15 |